Chronic spontaneous urticaria trials in United States

In United States 8 Also abroad 39

8 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Enrolling by invitation
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Where
Bakersfield, Baltimore, Bexley, Birmingham, Boynton Beach, Caledonia, Clackamas, Clarkston, Colorado Springs, Columbus, Dallas, Doral, El Paso, Findlay, Hialeah, Johnston, Laguna Niguel, Los Angeles, Margate, Miami, Miami Lakes, Missoula, Murray, New York, Ocean City, Omaha, Owensboro, Rockville, San Antonio, Sandy City, Sarasota, Scottsdale, Skokie, South Bend, St Louis, St. Petersburg, Tampa, Toledo, Waco, West Valley City, Wheaton, Ypsilanti
Age
18 years and over
People
1,370 worldwide
Run by
Celldex Therapeutics
See details and how to joinNCT07256392
Phase 2Taking people
A Study to Assess the Efficacy and Safety of THB335 in Adults With Chronic Spontaneous Urticaria (CSU)
Where
Altamonte Springs, Asheville, Atlanta, Austin, Baton Rouge, Boise, Houston, Pasadena, Prosper, Smyrna, Tampa, Ventura, Walnut Creek, White Marsh, Wildwood
Age
18 years to 85 years
People
81
Run by
Calixis Inc.
See details and how to joinNCT07766499 · EU 2026-526342-27-00
Phase 2Taking people
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Where
Ann Arbor, Austin, Bakersfield, Colorado Springs, Columbia, Fountain Valley, Lancaster, Little Rock, Long Beach, Oklahoma City, Pasadena, Phoenix, River Forest, San Antonio, Sugar Land, The Bronx, Troy, Tulsa, White Marsh
Age
18 years and over
People
200 worldwide
Run by
Pfizer
See details and how to joinNCT07219615 · EU 2025-522642-44-00
Phase 2Taking people
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
Where
Glenview, North Miami Beach
Age
18 years and over
People
44 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06865651 · EU 2024-516355-41-00
Phase 2Taking people
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
Where
Cincinnati, Glenview
Age
18 years to 65 years
People
42 worldwide
Run by
ARS Pharmaceuticals, Inc.
See details and how to joinNCT06927999
No phaseTaking people
A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients
Where
East Hanover
Age
18 years to 100 years
People
350
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07408219
No phaseTaking people
Remibrutinib in Real-world Clinical Practice
Where
Kirksville
Age
18 years and over
People
3,280
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07358364
No phaseTaking people
Remibrutinib in Real-world Clinical Practice - a US Sub-study
Where
Kirksville
Age
18 years to 100 years
People
505
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07358780